AlpVision to offer free of charge security feature to protect COVID-19 relevant medicines against counterfeiting
PR86548
VEVEY, Switzerland, Nov. 13, 2020 /PRNewswire=KYODO JBN/ --
On November 13th, 2020, AlpVision is launching the "AlpVision COVID-19
Initiative" helping pharmaceutical companies to protect COVID-19 relevant
medicines against counterfeiting.
COVID-19 has caused not only a worldwide health crisis, but also created
unprecedented economic challenges. In response, AlpVision has decided to launch
the "AlpVision COVID-19 Initiative". The initiative supports pharmaceutical
companies by providing them for free with the necessary tools to protect
COVID-19 relevant medicines and vaccines against counterfeiting.
To do so, AlpVision will provide pharmaceutical companies and their suppliers
with all necessary tools to deploy the Cryptoglyph on their packaging. The
AlpVision Cryptoglyph [https://alpvision.com/brand-protection/#cryptoglyph]is a
digital security feature which can be implemented and deployed within just a
few weeks. The Cryptoglyph is invisible to the human eye and authentication of
a product protected with a Cryptoglyph is done using a regular smartphone.
Securing of packaging with a Cryptoglyph is very easy as it neither changes the
standard production process, nor requires additional consumables. In addition,
the smartphone applications connect to AlpVision's Brand Monitoring System
(BMS)[https://alpvision.com/brand-protection/#bms], a centralized server
platform through which pharmaceutical companies are able to monitor in
real-time product authentication activities and gain important insight into
counterfeiting activities.
The "AlpVision COVID-19 Initiative" starts on November 13th, 2020, and
subscription will run for an initial period of three months. Participating
companies will be able to protect their COVID-19 relevant products with zero
additional cost for the authentication feature. AlpVision will provide this
service gratuitously until the pandemic is officially declared as ended by the
World Health Organization. Companies interested in participating in the
initiative are invited to contact AlpVision. More information can be found
online at www.alpvision.com/Covid/.
ALPVISION – MORE THAN ANTI-COUNTERFEIT SOLUTIONS
AlpVision was founded in 2001 and is the world's leader in digital
anti-counterfeiting technologies for product authentication and counterfeit
protection. AlpVision's digital anti-counterfeiting solutions for product
authentication are applicable to a wide variety of items, including packaging
and labelling, plastic and metal products, and high-value documents. AlpVision
anti-counterfeiting solutions are commercialized worldwide under license
agreements as entirely customizable turnkey computerized systems. Today
AlpVision protects over 30 billion of products each year.
More information is available at www.alpvision.com.
Join us on LinkedIn [https://linkedin.com/company/alpvision ] and
follow us on Twitter [https://twitter.com/alpvision].
Cryptoglyph and AlpVision are registered trademarks of AlpVision SA. Smart
Embossing, AlpVision Fingerprint® and Krypsos are trademarks of AlpVision SA.
Contact:
Martin Kutter
+41 21 948 6464
avinfo-20@alpvision.com
Photo - https://mma.prnewswire.com/media/1332078/AlpVision_Authentication.jpg
Logo - https://mma.prnewswire.com/media/1332077/AlpVision_Logo.jpg
Source: AlpVision
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。